PMHNP Practice Authority in Connecticut: Independence, Physician Agreements and Schedule II

AANP's May 2026 map puts Connecticut in its full practice tier, and AANP's November 2025 snapshot lists Connecticut among the full-practice states with a time-in-practice requirement.

Both are AANP's advocacy classifications; the legal facts sit in C.G.S. § 20-87a.

Full practice in Connecticut is a destination, not a starting point: the statute requires a collaboration with a physician for the first three years after licensure, and the subdivision (3) grant — alone or in collaboration, prescribing included — opens only once the licence and hours conditions are met and the written notice is given.

For a new graduate that means the first Connecticut job is a collaborating job; for a relocating PMHNP, the collaborating years already worked are the asset that matters.

The collaboration requirement attaches at licensure: an APRN shall, for the first three years after having been issued the licence, collaborate with a physician licensed to practice medicine in Connecticut.

Independence's lettered conditions, § 20-87a(b)(3)(A)–(C): a licence issued under § 20-94a, maintained for not less than three years — for subsection (d) licensees, an out-of-state APRN licence counts — plus collaboration with a physician for not less than three years and not less than two thousand hours.

Written notice is a separate duty, due after those requirements are completed and before practice without collaboration begins.

A subsection (d) licensee who collaborated, before the licence was issued, with a physician licensed in another state may count that time toward (2)(A)'s three-year requirement, provided the collaboration otherwise satisfies that subparagraph's requirements.

Documentation must be kept for not less than three years and produced to the department not later than forty-five days after a request, and DPH publishes an annual list of APRNs authorized to practice without collaboration by December 1.

During the three-year period the collaborator must be a physician, and the statute ties that physician's education, training or relevant experience to the APRN's work — for a PMHNP choosing a collaborator, that language points to physicians whose background matches psychiatric practice.

The collaboration must address a reasonable and appropriate level of consultation and referral, coverage for patients in the APRN's absence, a method to review patient outcomes and a method of disclosure of the relationship to the patient.

Relative to prescribing it must be in writing.

What § 20-87a does not set, as far as the text read goes: no ratio of APRNs per physician, no meeting frequency, no chart-review percentage, and no filing with a medical board.

Beyond the written prescribing collaboration, the paperwork the statute names is the written notice to the Commissioner before practising without collaboration and the collaboration documentation kept for DPH to inspect on request.

Schedule II and III controlled substances are prescribable by a Connecticut APRN.

Until the § 20-87a(b)(3) requirements are met, the written collaboration agreement sets the level of schedule II and III drugs the APRN may prescribe — which drugs, and how much latitude, is whatever the agreement says.

After the transition, § 20-87a as read contains no Schedule II day-supply or drug-class limit, so an outpatient PMHNP can prescribe ADHD stimulants so far as the sources read show.

Two caveats belong next to that answer: no separate state controlled-substance registration was located in the sources read, and the no-limit reading rests on the statute text alone — confirm the current text with DPH before relying on it.

Settings are not the restriction in Connecticut — personnel is.

Both during the first three years and after, the practice grant runs in all settings; what changes at independence is that a physician no longer has to be part of the prescribing relationship.

The statute also lets the APRN request, sign for, receive and dispense drugs in the form of professional samples, under sections 20-14c to 20-14e.

Federally, the PMHNP registers with the DEA as a mid-level practitioner, a registration that covers only what Connecticut allows, and the DEA/HHS telemedicine flexibilities — extended through December 31, 2026 — remove the federal in-person requirement without lifting the state's three-year collaboration.

Connecticut has not enacted the APRN Compact.

The compact takes effect only once seven states enact it, and as of September 2026 five had (Delaware, North Dakota, South Dakota, Utah and Wyoming), so no APRN holds a multistate APRN licence today.

The Nurse Licensure Compact is an RN compact and gives no nurse practitioner authority in another state.

To practise as a PMHNP in Connecticut you need Connecticut licensure under § 20-94a — and, for the first three years, a Connecticut-physician collaboration.

The official consolidated text of § 20-87a on cga.ct.gov — down (HTTP 500) when the sources were first gathered on 2026-09-24 — was retrieved on 2026-09-27, and it matches the FindLaw transcription on every provision this page relies on.

The official history block shows the most recent amendments: P.A.

23-97 (2023), which designated the first-three-years collaboration rules as (b)(2)(A), added (b)(2)(B) for APRNs who collaborated with a physician licensed in another state, and added a licensure-by-endorsement provision in (b)(3)(B); and P.A.

24-68, a technical change to (b)(2)(B) effective May 28, 2024.

Nothing later appears in the history.

Confirm the current text with the Department of Public Health before relying on it.